Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells
2011

Bacterial Endotoxin Activates Signaling Pathways in Human Blood Cells

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Andra L Blomkalns, Lynn L Stoll, Wassim Shaheen, Sara A Romig-Martin, Eric W Dickson, Neal L Weintraub, Gerene M Denning

Primary Institution: University of Cincinnati

Hypothesis

Low doses of E. coli LPS activate distinct signaling pathways in human peripheral blood mononuclear cells.

Conclusion

The study found that IL-8 release and superoxide production in response to low levels of endotoxin are regulated by different signaling pathways.

Supporting Evidence

  • IL-8 release was detectable at 10 pg/ml of endotoxin, peaking at 1 ng/ml.
  • Superoxide production was detectable at 30 pg/ml of endotoxin, peaking at 3 ng/ml.
  • Lovastatin inhibited LPS-dependent IL-8 release and superoxide production.

Takeaway

When bacteria release toxins into the blood, certain immune cells react in two different ways, which could help us find new treatments for diseases like heart problems.

Methodology

The study involved isolating human peripheral blood mononuclear cells and measuring IL-8 release and superoxide production in response to varying concentrations of E. coli LPS.

Potential Biases

Potential variability in individual responses to endotoxin due to genetic differences among donors.

Limitations

The study was limited to healthy volunteers, which may not represent responses in patients with chronic inflammatory diseases.

Participant Demographics

Healthy volunteers, n = 4.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-9255-8-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication